1. Home
  2. BZUN vs GBIO Comparison

BZUN vs GBIO Comparison

Compare BZUN & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BZUN
  • GBIO
  • Stock Information
  • Founded
  • BZUN 2007
  • GBIO 2016
  • Country
  • BZUN China
  • GBIO United States
  • Employees
  • BZUN N/A
  • GBIO N/A
  • Industry
  • BZUN Catalog/Specialty Distribution
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • BZUN Consumer Discretionary
  • GBIO Health Care
  • Exchange
  • BZUN Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • BZUN 166.3M
  • GBIO 145.5M
  • IPO Year
  • BZUN N/A
  • GBIO 2020
  • Fundamental
  • Price
  • BZUN $2.49
  • GBIO $2.50
  • Analyst Decision
  • BZUN Buy
  • GBIO Buy
  • Analyst Count
  • BZUN 2
  • GBIO 4
  • Target Price
  • BZUN $2.20
  • GBIO $7.50
  • AVG Volume (30 Days)
  • BZUN 231.2K
  • GBIO 63.3K
  • Earning Date
  • BZUN 08-28-2024
  • GBIO 08-07-2024
  • Dividend Yield
  • BZUN N/A
  • GBIO N/A
  • EPS Growth
  • BZUN N/A
  • GBIO N/A
  • EPS
  • BZUN N/A
  • GBIO N/A
  • Revenue
  • BZUN $1,235,027,314.00
  • GBIO $13,174,000.00
  • Revenue This Year
  • BZUN $5.22
  • GBIO $99.36
  • Revenue Next Year
  • BZUN $5.32
  • GBIO N/A
  • P/E Ratio
  • BZUN N/A
  • GBIO N/A
  • Revenue Growth
  • BZUN 5.56
  • GBIO 1397.05
  • 52 Week Low
  • BZUN $1.90
  • GBIO $0.86
  • 52 Week High
  • BZUN $3.55
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • BZUN 58.38
  • GBIO 49.32
  • Support Level
  • BZUN $2.23
  • GBIO $2.13
  • Resistance Level
  • BZUN $2.49
  • GBIO $2.49
  • Average True Range (ATR)
  • BZUN 0.11
  • GBIO 0.21
  • MACD
  • BZUN 0.03
  • GBIO 0.01
  • Stochastic Oscillator
  • BZUN 87.19
  • GBIO 46.91

About BZUN Baozun Inc.

Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: